rs9672065

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_022489.4(INF2):​c.3478G>A​(p.Gly1160Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00387 in 1,612,556 control chromosomes in the GnomAD database, including 150 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 65 hom., cov: 34)
Exomes 𝑓: 0.0024 ( 85 hom. )

Consequence

INF2
NM_022489.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -1.47

Publications

6 publications found
Variant links:
Genes affected
INF2 (HGNC:23791): (inverted formin 2) This gene represents a member of the formin family of proteins. It is considered a diaphanous formin due to the presence of a diaphanous inhibitory domain located at the N-terminus of the encoded protein. Studies of a similar mouse protein indicate that the protein encoded by this locus may function in polymerization and depolymerization of actin filaments. Mutations at this locus have been associated with focal segmental glomerulosclerosis 5.[provided by RefSeq, Aug 2010]
INF2 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease dominant intermediate E
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet
  • focal segmental glomerulosclerosis 5
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0020544827).
BP6
Variant 14-104714640-G-A is Benign according to our data. Variant chr14-104714640-G-A is described in ClinVar as [Benign]. Clinvar id is 312709.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0579 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INF2NM_022489.4 linkc.3478G>A p.Gly1160Ser missense_variant Exon 21 of 23 ENST00000392634.9 NP_071934.3 Q27J81-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INF2ENST00000392634.9 linkc.3478G>A p.Gly1160Ser missense_variant Exon 21 of 23 5 NM_022489.4 ENSP00000376410.4 Q27J81-1

Frequencies

GnomAD3 genomes
AF:
0.0178
AC:
2702
AN:
152190
Hom.:
65
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0600
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00739
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.000882
Gnomad OTH
AF:
0.0182
GnomAD2 exomes
AF:
0.00478
AC:
1179
AN:
246410
AF XY:
0.00371
show subpopulations
Gnomad AFR exome
AF:
0.0587
Gnomad AMR exome
AF:
0.00470
Gnomad ASJ exome
AF:
0.000101
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000186
Gnomad NFE exome
AF:
0.000883
Gnomad OTH exome
AF:
0.00384
GnomAD4 exome
AF:
0.00243
AC:
3542
AN:
1460248
Hom.:
85
Cov.:
37
AF XY:
0.00213
AC XY:
1546
AN XY:
726406
show subpopulations
African (AFR)
AF:
0.0659
AC:
2206
AN:
33478
American (AMR)
AF:
0.00503
AC:
225
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.000306
AC:
8
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.000174
AC:
15
AN:
86250
European-Finnish (FIN)
AF:
0.000307
AC:
16
AN:
52060
Middle Eastern (MID)
AF:
0.00572
AC:
33
AN:
5768
European-Non Finnish (NFE)
AF:
0.000675
AC:
751
AN:
1111796
Other (OTH)
AF:
0.00477
AC:
288
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
236
472
709
945
1181
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
86
172
258
344
430
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0178
AC:
2704
AN:
152308
Hom.:
65
Cov.:
34
AF XY:
0.0167
AC XY:
1241
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.0599
AC:
2489
AN:
41568
American (AMR)
AF:
0.00738
AC:
113
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.000882
AC:
60
AN:
68008
Other (OTH)
AF:
0.0180
AC:
38
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
136
272
408
544
680
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00367
Hom.:
15
Bravo
AF:
0.0202
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.0525
AC:
221
ESP6500EA
AF:
0.000712
AC:
6
ExAC
AF:
0.00588
AC:
711
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.000927
EpiControl
AF:
0.00119

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Aug 02, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 17, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 02, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Focal segmental glomerulosclerosis 5;C4302667:Charcot-Marie-Tooth disease dominant intermediate E Benign:1
Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Focal segmental glomerulosclerosis 5 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Focal segmental glomerulosclerosis Benign:1
Sep 04, 2020
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.66
CADD
Benign
0.013
DANN
Benign
0.46
DEOGEN2
Benign
0.018
.;T;.
Eigen
Benign
-2.1
Eigen_PC
Benign
-2.1
FATHMM_MKL
Benign
0.0019
N
LIST_S2
Benign
0.49
T;T;T
MetaRNN
Benign
0.0021
T;T;T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
-0.55
N;N;.
PhyloP100
-1.5
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-0.12
N;N;.
REVEL
Benign
0.17
Sift
Benign
0.60
T;T;.
Sift4G
Benign
0.94
T;T;T
Polyphen
0.0
B;B;.
Vest4
0.024
MVP
0.30
MPC
0.25
ClinPred
0.0012
T
GERP RS
-8.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.030
gMVP
0.072
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9672065; hg19: chr14-105180977; COSMIC: COSV99384705; COSMIC: COSV99384705; API